Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HIMS Hims & Hers Health Inc.

Trading 07-13 09:36:48 EDT

34.48

+0.10

+0.28%

High34.90	Low34.20	Vol447.89K
Open34.30	D1 Closing34.38	Amplitude2.04%
Mkt Cap7.97B	Tradable Cap7.26B	Total Shares231.07M
T/O15.49M	T/O Rate0.21%	Tradable Shares210.59M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HIMS","market":"US","secType":"STK","nameCN":"Hims & Hers Health Inc.","latestPrice":34.475,"timestamp":1783949807489,"preClose":34.38,"halted":0,"volume":447887,"delay":0,"changeRate":0.0027632344386270755,"floatShares":210594352,"shares":231071031,"eps":-0.09,"marketStatus":"Trading","change":0.095,"latestTime":"07-13 09:36:48 EDT","open":34.3,"high":34.9,"low":34.2,"amount":15486918.443832,"amplitude":0.020361,"askPrice":34.51,"askSize":24,"bidPrice":34.44,"bidSize":152,"shortable":3,"etf":0,"ttmEps":-0.09,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1783972800000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":34.38,"preHourTrading":{"tag":"盘前","latestPrice":34.3,"preClose":34.38,"latestTime":"09:29 EDT","volume":51118,"amount":1731326.7879599999,"timestamp":1783949399367,"change":-0.08,"changeRate":-0.002327,"amplitude":0.019779},"postHourTrading":{"tag":"盘后","latestPrice":34.2102,"preClose":34.38,"latestTime":"19:59 EDT","volume":131959,"amount":4528236.1298,"timestamp":1783727995448,"change":-0.1698,"changeRate":-0.004939,"amplitude":0.009889},"volumeRatio":2.088921,"impliedVol":1.1819,"impliedVolPercentile":0.9402},"requestUrl":"/m/hq/s/HIMS/wiki","defaultTab":"wiki","newsList":[{"id":"1172124435","title":"Movement Alert｜Hims & Hers Health Falls 5.36% in Regular Trading, Insider Selling Filings Add to Ongoing Fundamental Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1172124435","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172124435?lang=en_us&edition=fundamental","pubTime":"2026-07-10 22:25","pubTimestamp":1783693503,"startTime":"0","endTime":"0","summary":"On July 10, Hims & Hers Health fell 5.36% in regular trading, trading at approximately $33.80 per share, with turnover of $142 million. The decline was triggered by multiple insider holding change...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650755249","title":"Hims & Hers's Peptide Opportunity Remains in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2650755249","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650755249?lang=en_us&edition=fundamental","pubTime":"2026-07-10 00:14","pubTimestamp":1783613640,"startTime":"0","endTime":"0","summary":"1214 ET - Hims & Hers Health is likely to beat estimates and raise its full-year guidance when it reports second-quarter results, but its potential opportunity in peptides is the biggest thing on investors' minds, Truist Securities analysts say in a note. The analysts point to credit-card data from June, which shows strong trends in the telehealth company's GLP-1 business as the rest of its business remains stable, they say. However, the stock has gained lately due to enthusiasm around the company's potential in peptides, making for a tough risk-reward setup for shares heading into the Food and Drug Administration's advisory committee meeting later this month, which will consider several peptides, the analysts say. Even if the committee gives a favorable recommendation, Hims likely wouldn't see any meaningful revenue boost from a potential peptide offering before 2028, the analysts say.  Dow Jones NewswiresJuly 09, 2026 12:14 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HEAL","BK4196","THNR","HIMS","HIYY","HIMZ","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650296659","title":"Hims & Hers Health is Maintained at Neutral by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2650296659","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650296659?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:38","pubTimestamp":1783597080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings(END) Dow Jones NewswiresJuly 09, 2026 07:38 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","THNR","HMYY","HEAL","HIMS","HIMY","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650923855","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650923855","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650923855?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:50","pubTimestamp":1783590627,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Tarsus Pharmaceutica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMZ","HIYY","THNR","BK4196","HIMY","HEAL","HMYY","HIMS","TARS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138056586","title":"Movement Alert｜Hims & Hers Health Falls 5.11% in Regular Trading, Trading at $34.26","url":"https://stock-news.laohu8.com/highlight/detail?id=1138056586","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138056586?lang=en_us&edition=fundamental","pubTime":"2026-07-08 23:18","pubTimestamp":1783523937,"startTime":"0","endTime":"0","summary":"On July 8, Hims & Hers Health fell 5.11% in regular trading, trading at $34.26 USD/share, with Turnover of $156 million.Within the Health Care Services sector where Hims & Hers Health belongs,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119293070","title":"Movement Alert｜Hims & Hers Health Falls 5.2% in Pre-Market Trading, Trading at $34.45","url":"https://stock-news.laohu8.com/highlight/detail?id=1119293070","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119293070?lang=en_us&edition=fundamental","pubTime":"2026-07-08 16:47","pubTimestamp":1783500467,"startTime":"0","endTime":"0","summary":"On July 8, Hims & Hers Health fell 5.2% in pre-market trading, trading at $34.45 USD/share, with Turnover of $1.6849 million.Within the Health Care Services sector where Hims & Hers Health belongs,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649865930","title":"Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2649865930","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649865930?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:21","pubTimestamp":1783455682,"startTime":"0","endTime":"0","summary":"Hims & Hers CFO Oluyemi Okupe disposes of 7,163 common shares for $261,540.56Hims & Hers CFO Oluyemi Okupe sold 7,163 Class A shares at an average price of $36.49 on July 6, 2026.The sale followed the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL9VLQww:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HIMY","HIMZ","BK4196","THNR","HIMS","HIYY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127338403","title":"Movement Alert｜Hims & Hers Health Declines 5.02% in Regular Trading, Trading at $36.33","url":"https://stock-news.laohu8.com/highlight/detail?id=1127338403","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127338403?lang=en_us&edition=fundamental","pubTime":"2026-07-08 03:24","pubTimestamp":1783452252,"startTime":"0","endTime":"0","summary":"On July 8, Hims & Hers Health declined 5.02% in regular trading, trading at $36.33 USD/share, with Turnover of $323 million.Within the Health Care Services sector where Hims & Hers Health belongs,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141491554","title":"Movement Alert｜Hims & Hers Health Rises 5.14% in Regular Trading, Continued Momentum Following BofA Price Target Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=1141491554","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141491554?lang=en_us&edition=fundamental","pubTime":"2026-07-06 23:06","pubTimestamp":1783350400,"startTime":"0","endTime":"0","summary":"On July 6, Hims & Hers Health rose 5.14% in regular trading, reaching $38.69 per share with turnover of $1.86 billion, extending gains following a recent analyst upgrade.The upward momentum follows...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649690202","title":"Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649690202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649690202?lang=en_us&edition=fundamental","pubTime":"2026-07-05 14:00","pubTimestamp":1783231200,"startTime":"0","endTime":"0","summary":"Many Americans would love a drug that makes them fitter, sharper, and more attractive. The peptides industry aims to oblige, and sales may soon be off to the races, courtesy of the Trump Administratio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HEAL","PPH","IE00BKVL7J92.USD","NVO","OZEM","BK4532","LU1093756168.USD","NVOH","BK4599","THNR","BK4007","HIMY","HIMZ","BK4585","BK4588","HMYY","LU1093756325.SGD","NVOX","HIYY","IE00BZ1G4Q59.USD","LU0154236417.USD","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648503293","title":"Hims & Hers Health (HIMS) Secures $400 Million Financing, Is The Upside Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648503293","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648503293?lang=en_us&edition=fundamental","pubTime":"2026-07-02 14:41","pubTimestamp":1782974499,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) is back in focus after securing a $400 million financing arrangement with JPMorgan Chase Bank. This move improves liquidity while regulatory scrutiny of its peptide ambitions intensifies.\nSee our latest analysis for Hims & Hers Health.\nAt a share price of $37.57, Hims & Hers Health has seen strong short term momentum, with a 1 month share price return of 35.34% and 90 day share price return of 96.29%, while the 1 year total shareholder return declined 20.84% but the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-secures-400-million-financing-is-the-u","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-secures-400-million-financing-is-the-u","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HIMZ","BK4196","HIMS","HMYY","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648256529","title":"Hims & Hers Health - Receivables Purchase Agreement Has Initial 364-day Term, Extendable by Written Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2648256529","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648256529?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:03","pubTimestamp":1782939813,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nFWN433146:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMZ","BK4196","HMYY","HIYY","HIMY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648529254","title":"Hims & Hers Signs USD 400 Million Receivables Purchase Facility with Jpmorgan Chase","url":"https://stock-news.laohu8.com/highlight/detail?id=2648529254","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648529254?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:03","pubTimestamp":1782939803,"startTime":"0","endTime":"0","summary":"Hims & Hers signs USD 400 million receivables purchase facility with JPMorgan ChaseHims & Hers subsidiaries XeCare, Apostrophe Pharmacy entered a Master Receivables Purchase Agreement with JPMorgan on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL96VZhv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BWXC8680.SGD","LU0211331839.USD","HIMS","LU1668664300.SGD","LU2552382215.SGD","LU0345770308.USD","LU0882574139.USD","LU1894683348.USD","LU2430703095.HKD","LU1629891620.HKD","LU2381873111.SGD","IE00BFXG1179.USD","LU0256863902.USD","IE00B1BXHZ80.USD","BK4516","LU2746668974.SGD","IE00BDCRKT87.USD","LU2244417387.USD","LU1162221912.USD","LU1244550494.USD","LU2430703251.USD","BK4533","LU0187121727.USD","LU0265550359.USD","LU1145028129.USD","SG9999002232.USD","LU1917777945.USD","LU2746668461.USD","LU2023250843.SGD","LU1116320901.HKD","LU2106854487.HKD","LU0234570918.USD","HIMY","LU0106831901.USD","LU0859254822.USD","LU0868494708.USD","LU2237443978.SGD","IE00BKVL7J92.USD","IE0034235188.USD","LU1670628061.USD","LU1670627923.USD","IE00BJTD4N35.SGD","IE000M9KFDE8.USD","LU0496365809.HKD","IE00BJLML261.HKD","LU0070302665.USD","LU2237443465.HKD","LU1551013342.USD","LU2023250330.USD","LU2430703178.SGD","IE00BLSP4239.USD","LU1548497426.USD","LU2236285917.USD","LU1084165304.USD","IE0034235303.USD","LU0820562030.AUD","LU1267930490.SGD","LU0320765646.SGD","LU2023250504.SGD","BK4534","LU0211326755.USD","LU0267386448.USD","LU1244550577.SGD","LU2264538146.SGD","IE00BLSP4452.SGD","BK4581","LU0964807845.USD","LU1064131342.USD","LU2357305700.SGD","IE00BN8TJ469.HKD","LU0942090050.USD","IE00BBT3K403.USD","LU2054465674.USD","LU2592432038.USD","LU0203347892.USD","LU2211815571.USD","LU0048584097.USD","LU0868494617.USD","LU1894683264.USD","SG9999002224.SGD","BK4585","IE00BHPRN162.USD","LU2552382058.USD","LU0238689110.USD","LU0971096721.USD","LU1363072403.SGD","LU1496350502.SGD","LU2237443549.SGD","LU0820561818.USD","LU1280957306.USD","LU2552382132.HKD","JPX","LU0170899867.USD","LU1366192091.USD","LU2357627491.SGD","LU0640476718.USD","LU1496350171.SGD","LU1720051017.SGD","BK4566","LU2417539215.USD","JPM","LU2505996681.GBP","LU1116320737.USD","LU0256863811.USD","LU1244550221.USD","JPMO","IE00B1XK9C88.USD","LU2213496289.HKD","LU2237443622.USD","LU0234572021.USD","LU0943347566.SGD","LU2456880835.USD","LU1720051108.HKD","LU0417517546.SGD","LU0689472784.USD","IE0034235295.USD","LU1119994496.HKD","LU0208291251.USD","LU2237443895.HKD","IE00BJTD4V19.USD","BK4588","LU1974910355.USD","LU2505996509.AUD","IE00B775SV38.USD","LU0345769631.USD","LU1032466523.USD","LU0211327993.USD","LU0310799852.SGD","LU0251132253.USD","HIMZ","LU1914381329.SGD","IE00BZ1G4Q59.USD","LU2237443382.USD","LU0203345920.USD","IE00BKDWB100.SGD","LU0323591593.USD","LU0976567544.SGD","LU0320765489.SGD","LU0211328371.USD","LU0265550946.USD","LU0820561909.HKD","LU0345770993.USD","JPO","LU2462157665.USD","IE00BDRTCR15.USD","LU2756315664.SGD","BK4207","IE00BYXW3230.USD","LU0211326839.USD","LU0149725797.USD","LU1551013425.SGD","BK4550","LU0787776722.HKD","HMYY","LU2242649171.HKD","LU0345769128.USD","HIYY","LU0683600562.USD","BK4504","LU1261432733.SGD","LU0106261372.USD","IE00B3S45H60.SGD","LU0215105999.USD","BK4196","LU0006306889.USD","LU2756315318.SGD","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648540507","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2648540507","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648540507?lang=en_us&edition=fundamental","pubTime":"2026-07-02 01:19","pubTimestamp":1782926397,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index increasing 0.1% and the State Street Health Care Select Sector SPDR ETF  adding 0.4%.The iShares Biotechnology ETF  was fractionally higher.In corporate news, Hims & Hers Health  shares jumped past 8% after BofA Securities lifted the company's price target to $36 from $25, while keeping its neutral rating.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCSG","XBI","BK4137","LU0029874061.USD","XLV","HIMS","HMYY","LABU","BK4196","BK4588","LU0128526141.USD","BK4581","HIYY","HIMY","BK4585","HIMZ","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125204684","title":"Movement Alert｜Hims & Hers Health Rises 5.12% in Regular Trading, BofA Securities Raises Price Target to $36 From $25","url":"https://stock-news.laohu8.com/highlight/detail?id=1125204684","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125204684?lang=en_us&edition=fundamental","pubTime":"2026-07-01 22:33","pubTimestamp":1782916390,"startTime":"0","endTime":"0","summary":"On July 1, Hims & Hers Health rose 5.12% in regular trading, trading at $37.23/share, with turnover of $340 million. The rally was driven by BofA Securities significantly raising its price target on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648940549","title":"BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2648940549","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648940549?lang=en_us&edition=fundamental","pubTime":"2026-07-01 22:06","pubTimestamp":1782914817,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) has an average rating of Hold and mean price target of $29.27, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HIMY","HIMZ","BK4196","HIMS","HIYY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648543734","title":"Hims & Hers Health is Maintained at Neutral by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2648543734","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648543734?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:52","pubTimestamp":1782910320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings(END) Dow Jones NewswiresJuly 01, 2026 08:52 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMZ","HIMS","HIMY","HIYY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648154824","title":"HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2648154824","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648154824?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:16","pubTimestamp":1782908218,"startTime":"0","endTime":"0","summary":"Shares of Hims & Hers ($HIMS) rose in pre-market trading after receiving a new Street-high price target of $40. Canaccord Genuity analyst Maria Rip...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-stock-jumps-after-canaccord-raises-price-target-to-street-high-of-40?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-stock-jumps-after-canaccord-raises-price-target-to-street-high-of-40?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMY","HMYY","HIMZ","HIMS","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648510005","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648510005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648510005?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:01","pubTimestamp":1782907265,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims &...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-oruka-therapeutics-orka-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-oruka-therapeutics-orka-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU1983299246.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","BK4599","LU1571399168.USD","LU2089984988.USD","IE0002141913.USD","LU0889565916.HKD","IE00B2B36J28.USD","BK4139","IE00BJT1NW94.SGD","BK4566","BK4196","ORKA","LU1023059063.AUD","HIMY","LU0058720904.USD","BK4585","HIMZ","LU0868494617.USD","HIMS","IE0009355771.USD","LU1061106388.HKD","BK4534","IE00BJJMRZ35.SGD","BK4581","LU1057294990.SGD","LU2112291526.USD","LU0320765992.SGD","LU2242646821.SGD","LU0289739699.SGD","LU2242652126.USD","BK4588","04332","IE00B4R5TH58.HKD","AMGN","HIYY","LU0122379950.USD","LU2468319806.SGD","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648517550","title":"Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2648517550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648517550?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:05","pubTimestamp":1782903937,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nAZN4T5E2P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HIMZ","HIYY","HIMY","HMYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0658},{"period":"1month","weight":0.2376},{"period":"3month","weight":0.7694},{"period":"6month","weight":0.0849},{"period":"1year","weight":-0.3161},{"period":"ytd","weight":0.0588}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1111},{"period":"6month","weight":0.0877},{"period":"1year","weight":0.2063},{"period":"ytd","weight":0.1071}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.098962},{"month":2,"riseRate":0.571429,"avgChangeRate":0.066017},{"month":3,"riseRate":0.428571,"avgChangeRate":0.011001},{"month":4,"riseRate":0.428571,"avgChangeRate":0.018546},{"month":5,"riseRate":0.428571,"avgChangeRate":0.15891},{"month":6,"riseRate":0.714286,"avgChangeRate":0.028446},{"month":7,"riseRate":0.571429,"avgChangeRate":0.06158},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.14623},{"month":9,"riseRate":0.5,"avgChangeRate":0.080437},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.073266},{"month":11,"riseRate":0.714286,"avgChangeRate":0.187933},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.001486}],"exchange":"NYSE","name":"Hims & Hers Health Inc.","nameEN":"Hims & Hers Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Hims & Hers Health Inc.(HIMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Hims & Hers Health Inc.,HIMS,Hims & Hers Health Inc.股票,Hims & Hers Health Inc.股票老虎,Hims & Hers Health Inc.股票老虎国际,Hims & Hers Health Inc.行情,Hims & Hers Health Inc.股票行情,Hims & Hers Health Inc.股价,Hims & Hers Health Inc.股市,Hims & Hers Health Inc.股票价格,Hims & Hers Health Inc.股票交易,Hims & Hers Health Inc.股票购买,Hims & Hers Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Hims & Hers Health Inc.(HIMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction